摘要
目的:本文旨在研究集扎鲁司特对于支气管哮喘急性期的疗效、安全性及患者情绪的影响。方法:选取我院治疗的支气管哮喘患者102例,单盲随机分为两组,分别采用扎鲁司特联合布地奈德和布地奈德。结果:联合用药组的治疗有效率明显高于布地奈德组,安全性较高,并且能够有效地改善患者的情绪状况。结论:扎鲁司特能够安全有效地缓解支气管哮喘患者的症状,同时改善支气管哮喘患者的情绪状况。
Objective:We aim to analyze the clinical value of zafirlukast on the response rate,security and mood of asthma acute phase patients.Methods:Select 102 asthma acute phase patients in our hospital,we divided the patients into 2 groups randomly,the 2 groups received zafirlukast combined with budesonide and budesonide Result: In the combined drugs goup,the response rate is more excellent and safer than control goup,and zafirlukast can improve the mood of the patients effectively.Conclusion: Zafirlukast can treat asthma effectively and safely,in the same time,it can improve the mood of asthma patients obviously.
出处
《中国医药导刊》
2013年第7期1211-1212,共2页
Chinese Journal of Medicinal Guide